Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check5 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check13 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference5%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check49 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check63 days agoChange DetectedThe date has been updated from February 13, 2025, to May 14, 2025.SummaryDifference0.7%
Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.